Azimuth Capital Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Azimuth Capital Investment Management's RMD Position: Q2 2026 in Review
Azimuth Capital Investment Management increased its ResMed (RMD) stake by 0.4% in Q2 2026, buying an estimated $44.6K and bringing the position to 54,490 shares worth $10.6M. The position accounts for 0.36% of the portfolio, ranked #91.
Azimuth Capital Investment Management first reported a position in RMD in Q2 2022 and has held it in 17 quarters since. The position peaked at $15.2M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Azimuth Capital Investment Management held 54,490 shares of ResMed worth $10.6M as of Q2 2026.
- Azimuth Capital Investment Management bought 215 ResMed shares in Q2 2026, an estimated $44.6K.
- ResMed made up 0.36% of Azimuth Capital Investment Management's portfolio in Q2 2026, its #91 holding.
- Azimuth Capital Investment Management first reported a position in ResMed in Q2 2022 and has held it in 17 quarters since.
- Azimuth Capital Investment Management's ResMed position peaked at $15.2M in Q3 2025.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Azimuth Capital Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.